3 Been-There-Done-That Biotech CEOs Who Are Doing it Again
You might want to turn back the clock so that you can profit from Puma Biotechnology's (NASDAQ: PBYI) 212% return this year, but unfortunately, you can't. Instead, you'll just have to go out and find the next big biotech winner -- and to manage that, you're going to have to do your homework.
Fortunately, The Motley Fool's Kristine Harjes and Todd Campbell are here to help! In today's episode of The Motley Fool's Industry Focus: Healthcare podcast, the two discuss how Puma Biotechnology's experienced management team helped it deliver a big win, and why proven leaders at Aurinia Pharmaceuticals (NASDAQ: AUPH), Axovant Sciences (NYSE: AXON), and Esperion Therapeutics (NASDAQ: ESPR) might someday deliver similar success.
A full transcript follows the video.
Source: Fool.com
